oral tirzepatide fda approved Grants a New Indication for Obesity Management FDA approval for Zepbound (tirzepatide)

This serum is formulated with powerful skin-lightening ingredients that work together to reduce the appearance of hyperpigmentation while brightening the skin

Medical Weight Loss Panel Purpose: Assesses blood sugar control, metabolism, overall health, and organ function before starting treatment

Primary Care Plan J1

NAION Symptoms May Include: Sudden blurred or dim vision (often in one eye) Loss of peripheral (side) vision Dark patches in your field of view Reduced contrast sensitivity or color perception Sudden vision loss upon waking Difficulty seeing in low light or bright glare Ozempic and the Risk of NAION In August 2024, a groundbreaking study published in JAMA Ophthalmology identified a significantly higher rate of NAION among people taking semaglutide (the active ingredient in Ozempic and Wegovy) medications compared to those on non-semiglutide diabetes medications

Chronic oxidative injury modifies membranes, denatures proteins, and induces strand breaks in DNA that can result in cell death or erroneous repair that causes dysfunction